604 related articles for article (PubMed ID: 19713701)
1. Differentiation between mild cognitive impairment and Alzheimer's disease using the FMLL mini-battery.
Abizanda P; López-Ramos B; Romero L; Sánchez-Jurado PM; León M; Martín-Sebastiá E; López-Jiménez E
Dement Geriatr Cogn Disord; 2009; 28(2):179-86. PubMed ID: 19713701
[TBL] [Abstract][Full Text] [Related]
2. [Validation of the Short Cognitive Battery (B2C). Value in screening for Alzheimer's disease and depressive disorders in psychiatric practice].
Robert PH; Schuck S; Dubois B; Lépine JP; Gallarda T; Olié JP; Goni S; Troy S
Encephale; 2003; 29(3 Pt 1):266-72. PubMed ID: 12876552
[TBL] [Abstract][Full Text] [Related]
3. Does the combination of the MMSE and clock drawing test (mini-clock) improve the detection of mild Alzheimer's disease and mild cognitive impairment?
Cacho J; Benito-León J; García-García R; Fernández-Calvo B; Vicente-Villardón JL; Mitchell AJ
J Alzheimers Dis; 2010; 22(3):889-96. PubMed ID: 20858951
[TBL] [Abstract][Full Text] [Related]
4. Validation of the German revised Addenbrooke's cognitive examination for detecting mild cognitive impairment, mild dementia in alzheimer's disease and frontotemporal lobar degeneration.
Alexopoulos P; Ebert A; Richter-Schmidinger T; Schöll E; Natale B; Aguilar CA; Gourzis P; Weih M; Perneczky R; Diehl-Schmid J; Kneib T; Förstl H; Kurz A; Danek A; Kornhuber J
Dement Geriatr Cogn Disord; 2010; 29(5):448-56. PubMed ID: 20502019
[TBL] [Abstract][Full Text] [Related]
5. Differentiation between mild cognitive impairment, Alzheimer's disease and depression by means of cued recall.
Dierckx E; Engelborghs S; De Raedt R; De Deyn PP; Ponjaert-Kristoffersen I
Psychol Med; 2007 May; 37(5):747-55. PubMed ID: 17164030
[TBL] [Abstract][Full Text] [Related]
6. Brief screening tool for mild cognitive impairment in older Japanese: validation of the Japanese version of the Montreal Cognitive Assessment.
Fujiwara Y; Suzuki H; Yasunaga M; Sugiyama M; Ijuin M; Sakuma N; Inagaki H; Iwasa H; Ura C; Yatomi N; Ishii K; Tokumaru AM; Homma A; Nasreddine Z; Shinkai S
Geriatr Gerontol Int; 2010 Jul; 10(3):225-32. PubMed ID: 20141536
[TBL] [Abstract][Full Text] [Related]
7. [Discriminatory validity and association of the mini-mental test (MMSE) and the memory alteration test (M@T) with a neuropsychological battery in patients with amnestic mild cognitive impairment and Alzheimer's disease].
Rami L; Bosch B; Valls-Pedret C; Caprile C; Sánchez-Valle Díaz R; Molinuevo JL
Rev Neurol; 2009 Aug 16-31; 49(4):169-74. PubMed ID: 19621317
[TBL] [Abstract][Full Text] [Related]
8. CAMcog as a screening tool for diagnosis of mild cognitive impairment and dementia in a Brazilian clinical sample of moderate to high education.
Nunes PV; Diniz BS; Radanovic M; Abreu ID; Borelli DT; Yassuda MS; Forlenza OV
Int J Geriatr Psychiatry; 2008 Nov; 23(11):1127-33. PubMed ID: 18464287
[TBL] [Abstract][Full Text] [Related]
9. Screening of mild cognitive impairment in Chinese older adults--a multistage validation of the Chinese abbreviated mild cognitive impairment test.
Lam LC; Tam CW; Lui VW; Chan WC; Chan SS; Chiu HF; Leung T; Tham MK; Ho KS; Chan WM
Neuroepidemiology; 2008; 30(1):6-12. PubMed ID: 18204291
[TBL] [Abstract][Full Text] [Related]
10. [Mild cognitive impairment and Alzheimer's disease: an investigation of the CERAD-NP test battery].
Barth S; Schönknecht P; Pantel J; Schröder J
Fortschr Neurol Psychiatr; 2005 Oct; 73(10):568-76. PubMed ID: 16217697
[TBL] [Abstract][Full Text] [Related]
11. Screening for amnestic mild cognitive impairment and early Alzheimer's disease with M@T (Memory Alteration Test) in the primary care population.
Rami L; Molinuevo JL; Sanchez-Valle R; Bosch B; Villar A
Int J Geriatr Psychiatry; 2007 Apr; 22(4):294-304. PubMed ID: 16998781
[TBL] [Abstract][Full Text] [Related]
12. The validity and reliability of the Turkish version of Alzheimer's Disease Assessment Scale-Cognitive Subscale (ADAS-Cog) in patients with mild and moderate Alzheimer's disease and normal subjects.
Mavioglu H; Gedizlioglu M; Akyel S; Aslaner T; Eser E
Int J Geriatr Psychiatry; 2006 Mar; 21(3):259-65. PubMed ID: 16477580
[TBL] [Abstract][Full Text] [Related]
13. Mild cognitive impairment as predictor for Alzheimer's disease in clinical practice: effect of age and diagnostic criteria.
Visser PJ; Verhey FR
Psychol Med; 2008 Jan; 38(1):113-22. PubMed ID: 17451628
[TBL] [Abstract][Full Text] [Related]
14. A total score for the CERAD neuropsychological battery.
Chandler MJ; Lacritz LH; Hynan LS; Barnard HD; Allen G; Deschner M; Weiner MF; Cullum CM
Neurology; 2005 Jul; 65(1):102-6. PubMed ID: 16009893
[TBL] [Abstract][Full Text] [Related]
15. Linear measures of temporal lobe atrophy on brain magnetic resonance imaging (MRI) but not visual rating of white matter changes can help discrimination of mild cognitive impairment (MCI) and Alzheimer's disease (AD).
Saka E; Dogan EA; Topcuoglu MA; Senol U; Balkan S
Arch Gerontol Geriatr; 2007; 44(2):141-51. PubMed ID: 16723158
[TBL] [Abstract][Full Text] [Related]
16. [Validity of the Spanish version of the Addenbrooke's Cognitive Examination for the diagnosis of dementia and to differentiate Alzheimer's disease and frontotemporal dementia].
Sarasola D; de Luján-Calcagno M; Sabe L; Crivelli L; Torralva T; Roca M; García-Caballero A; Manes F
Rev Neurol; 2005 Dec 16-31; 41(12):717-21. PubMed ID: 16355355
[TBL] [Abstract][Full Text] [Related]
17. [Outcome and cognitive changes of mild cognitive impairment in the elderly: a follow-up study of 47 cases].
Xiao SF; Xue HB; Li GJ; Li CB; Wu WY; Zhang MY
Zhonghua Yi Xue Za Zhi; 2006 Jun; 86(21):1441-6. PubMed ID: 16842692
[TBL] [Abstract][Full Text] [Related]
18. [Validation of the Rapid BAttery of Denomination (BARD) in 382 controls and 1004 patients of a memory clinic].
Croisile B; Astier JL; Beaumont C; Mollion H
Rev Neurol (Paris); 2010; 166(6-7):584-93. PubMed ID: 20226490
[TBL] [Abstract][Full Text] [Related]
19. Amnestic syndrome of the medial temporal type identifies prodromal AD: a longitudinal study.
Sarazin M; Berr C; De Rotrou J; Fabrigoule C; Pasquier F; Legrain S; Michel B; Puel M; Volteau M; Touchon J; Verny M; Dubois B
Neurology; 2007 Nov; 69(19):1859-67. PubMed ID: 17984454
[TBL] [Abstract][Full Text] [Related]
20. Severe Impairment Battery Language scale: a language-assessment tool for Alzheimer's disease patients.
Ferris S; Ihl R; Robert P; Winblad B; Gatz G; Tennigkeit F; Gauthier S
Alzheimers Dement; 2009 Sep; 5(5):375-9. PubMed ID: 19751916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
